INO Stock Summary and Trading Ideas (Inovio Pharmaceuticals | NASDAQ:INO)

Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals trades on the NASDAQ stock market under the symbol INO.

As of March 3, 2025, INO stock price declined to $1.84 with 553,124 million shares trading.

INO has a beta of 3.11, meaning it tends to be more sensitive to market movements. INO has a correlation of 0.18 to the broad based SPY ETF.

INO has a market cap of $66.42 million. This is considered a Micro Cap stock.

Last quarter Inovio Pharmaceuticals reported $0 in Revenue and -$.89 earnings per share. This fell short of revenue expectation by $-104,500 and exceeded earnings estimates by $.24.

In the last 3 years, INO traded as high as $48.00 and as low as $1.74.

The top ETF exchange traded funds that INO belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

INO has underperformed the market in the last year with a price return of -80.7% while the SPY ETF gained +15.2%. INO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -56.2% and -14.4%, respectively, while the SPY returned -3.0% and -4.3%, respectively.

INO support price is $1.87 and resistance is $2.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INO shares will trade within this expected range on the day.